These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10113412)

  • 1. Nonionic agents: okay, they're safer--now what?
    Wolf G
    Adm Radiol; 1990 Nov; 9(11):92, 96. PubMed ID: 10113412
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonionic agents: okay, they're safer--but how much safer and at what cost to society?
    Levin D
    Adm Radiol; 1990 Nov; 9(11):97-8. PubMed ID: 10113413
    [No Abstract]   [Full Text] [Related]  

  • 3. 100% nonionics: everything added up.
    von Kaenel LH; Modic M
    Adm Radiol; 1990 Nov; 9(11):100-6. PubMed ID: 10113410
    [No Abstract]   [Full Text] [Related]  

  • 4. Indications for the use of low-osmolar contrast agents.
    Bloom DM
    Physician Exec; 1989; 15(4):24-5. PubMed ID: 10313370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonionic contrast agents: clinical and cost considerations.
    Wolf G
    Radiol Manage; 1986 Jul; 8(3):66-8. PubMed ID: 10311703
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravascular contrast media.
    Hosp Pharm; 1991 Mar; 26(3):275-6, 278. PubMed ID: 10113525
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk management issues in the use of iodinated radiopaque contrast media.
    Ratko T
    QRC Advis; 1994 Jun; 10(8):1-3. PubMed ID: 10134831
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes & choices. AR nationwide survey.
    Tsuchiyama S
    Adm Radiol; 1988 Nov; 7(11):70-4, 76-8. PubMed ID: 10291083
    [No Abstract]   [Full Text] [Related]  

  • 9. They're measuring the quality of patient care.
    Powers WE
    Am Med News; 1979 Apr; 22(17):suppl 4-5. PubMed ID: 10308881
    [No Abstract]   [Full Text] [Related]  

  • 10. An institutional approach to developing guidelines for the use of low-osmolality contrast agents.
    Swanson DP
    Appl Radiol; 1988 May; 17(5):27-8. PubMed ID: 10287384
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced use of lower-osmolality contrast media resulting from an order form and guidelines.
    Swanson DP; Damiani-Hieronim DR; Baron RL
    Am J Hosp Pharm; 1994 Dec; 51(23):2952-5. PubMed ID: 7879806
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospitals begin cutting non-ionic contrast agent use.
    Werner C
    Hosp Mater Manage; 1993 Oct; 18(10):1, 11-2. PubMed ID: 10129785
    [No Abstract]   [Full Text] [Related]  

  • 13. The contrast media controversy: implications of a landmark safety study.
    Katayama H
    Adm Radiol; 1990 Sep; 9(9):20-2. PubMed ID: 10113386
    [No Abstract]   [Full Text] [Related]  

  • 14. Fear of a white hat.
    Shearer DR
    Radiol Manage; 1998; 20(6):14. PubMed ID: 10338847
    [No Abstract]   [Full Text] [Related]  

  • 15. Survey of contrast media use in southeastern U.S. hospitals.
    Utter DP
    Radiol Technol; 1997; 68(5):386-90. PubMed ID: 9170181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Errors rare in nuclear medicine.
    Radiol Technol; 2006; 77(4):328-9. PubMed ID: 16543485
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical pathways to utilization review.
    Karcz A
    Adm Radiol; 1995 Aug; 14(8):23-5. PubMed ID: 10151503
    [No Abstract]   [Full Text] [Related]  

  • 18. The quality-service connection.
    Valdez F
    Adm Radiol; 1995 Aug; 14(8):16, 19-21. PubMed ID: 10151502
    [No Abstract]   [Full Text] [Related]  

  • 19. The regulation of silver recovery.
    Rhodes R; Rubin M
    Radiol Manage; 1998; 20(5):19-21. PubMed ID: 10186413
    [No Abstract]   [Full Text] [Related]  

  • 20. The power of ultrasound.
    Ginsburg E; Kinsley MD; Quitral A
    Adm Radiol J; 1998 May; 17(5):17-20. PubMed ID: 10181987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.